Canine Cancer Chemotherapy Study
Learn more about the Canine Cancer Chemotherapy Study including eligibility, treatment, and how dogs can participate in this clinical trial.
About the Canine Cancer Chemotherapy Study
This study will require dogs to be hospitalized for 5 hours, all study appointments will be scheduled for early morning drop off.
To be eligible to participate canines must be:
- Client-owned dogs, either sex and reproductive status, aged 12 months and older.
- Diagnosed with malignant melanoma, hemangiosarcoma, breast/mammary cancer, soft tissue sarcomas, and spindle cell carcinoma, with validation.
- No known or suspected medical condition that could interfere with the treatment outcome and/or effectiveness.
- No planned procedures involving general anesthesia for the dog during the study.
- Has not previously received corticosteroids, chemotherapy, immunotherapy or radiation.
- Free physical exam, bloodwork and chemotherapy will be provided.
Please refer questions and interest in study participation to:
- Dr. Kara Thomas: kthoma@midwestern.edu
- Dr. Natacha Montalvo: nmonta@midwestern.edu